How To Write Covered Calls - An Ongoing Real Case Study! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : How To Write Covered Calls - An Ongoing Real Case Study!

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Maureen who wrote (1863)	4/25/1997 9:16:00 AM
From: Chuck Molinary	of 14162

Maureen, I too checked out CEPH. Did you read this news? biz.yahoo.com The FDA will be reviewing Myotrophin (jointly developed with Chiron) on May 8. My speculation would be that if CEPH is willing to buy options on themselves, they are confident that this review will go well. I'm going to look into it further although I know zilch about drugs (I do know enough to buy and hold Merck for the long term, however). Thanks for the info.... ctm

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next